Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia
Abstract Chronic myeloid leukemia (CML) is a hematological tumor derived from hematopoietic stem cells. The aim of this study is to analyze the biological characteristics and identify the diagnostic markers of CML. We obtained the expression profiles from the Gene Expression Omnibus (GEO) database a...
Main Authors: | Fang-Min Zhong, Fang-Yi Yao, Yu-Lin Yang, Jing Liu, Mei-Yong Li, Jun-Yao Jiang, Nan Zhang, Yan-Mei Xu, Shu-Qi Li, Ying Cheng, Shuai Xu, Bo Huang, Xiao-Zhong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-023-02905-x |
Similar Items
-
A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
by: Hai-Bin Zhang, et al.
Published: (2022-08-01) -
Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
by: Jingjing Pan, et al.
Published: (2022-06-01) -
Immune‐related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia
by: Qiang Xu, et al.
Published: (2022-09-01) -
The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia
by: Fangmin Zhong, et al.
Published: (2024-07-01) -
Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment
by: Denggang Fu, et al.
Published: (2023-08-01)